Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.60 |
| ▸ | NPC1 | O15118 | 7/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.52 |
| ▸ | MEN1 | O00255 | 10/20 | 0.52 |
| ▸ | MAPT | P10636 | 9/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 5/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MITF | O75030 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29371749 | 1.00 | RAB9A (0.60) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL3880149 | 1.00 | RAB9A (0.60) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL3880145 | 1.00 | RAB9A (0.60) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL13929252 | 0.94 | RAB9A (0.67) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL7510330 | 0.92 | RAB9A (0.64) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL11553982 | 0.92 | RAB9A (0.64) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL11553978 | 0.92 | RAB9A (0.64) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL7508570 | 0.87 | ALDH1A1 (0.60) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL7508574 | 0.87 | ALDH1A1 (0.60) | RAB9ANPC1L3MBTL1KMT2AMEN1 | |
| SCHEMBL11421677 | 0.85 | RAB9A (0.68) | RAB9ANPC1L3MBTL1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140038305-A1 | ARTICLES AND METHODS FOR THE DETECTION AND QUANTIFICATION OF ULTRAVIOLET LIGHT | PROPPER MANUFACTURING COMPANY, INC. (US) | 2014-02-06 | — | — | US | claimed |
| US-4056485-A | STABLE COLORED REFERENCE STANDARD FOR ENZYMATIC DETERMINATIONS | WARNER-LAMBERT COMPANY (US) | 1977-11-01 | — | — | US | claimed |
| CN-119913211-A | Iron nanoparticle-mediated cascade electron transfer for improving microbial biosynthesis | 上海交通大学 | 2025-05-02 | — | — | CN | disclosed |
| EP-4465976-A1 | USES AND METHODS FOR PROMOTING INCREASED MITOCHONDRIAL MASS AND FUNCTION | Brightseed, Inc. (US) | 2024-11-27 | — | — | EP | disclosed |
| CN-119013005-A | Use and method for promoting mitochondrial mass and function enhancement | 布莱特西德公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20240374546-A1 | USES AND METHODS FOR PROMOTING INCREASED MITOCHONDRIAL MASS AND FUNCTION | BRIGHTSEED INC (US) | 2024-11-14 | — | — | US | disclosed |
| US-20240310288-A1 | TETRAZOLIUM-BASED COLORIMETRIC ASSAY | UNIVERSITY OF SOUTH CAROLINA | 2024-09-19 | — | — | US | disclosed |
| EP-4216944-B1 | NEW THERAPY CONCEPT FOR THE TREATMENT OF CORONA INFECTIONS, MORE PARTICULARLY COVID-19 INFECTIONS | MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGES MBH (DE) | 2024-08-07 | — | — | EP | disclosed |
| US-20240033285-A1 | BICARBONATE AS A POTENTIATOR FOR ANTIMICROBIAL AGENTS | UNIV MCMASTER (CA) | 2024-02-01 | — | — | US | disclosed |
| US-20230414557-A1 | NEW THERAPY CONCEPT FOR THE TREATMENT OF CORONA INFECTIONS, ESPECIALLY COVID-19 INFECTIONS | MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBH (DE) | 2023-12-28 | — | — | US | disclosed |
| US-20230390328-A1 | Bicarbonate as a Potentiator for Antimicrobial Agents | MCMASTER UNIVERSITY (CA) | 2023-12-07 | — | — | US | disclosed |
| US-20130052675-A1 | TESTING SYSTEM FOR DETERMINING HYPOXIA INDUCED CELLULAR DAMAGE | CALMARK SWEDEN AKTIEBOLAG (SE) | 2013-02-28 | — | — | US | disclosed |
| EP-2483419-A1 | TESTING SYSTEM FOR DETERMINING HYPOXIA INDUCED CELLULAR DAMAGE | Calmark Sweden Aktiebolag (SE) | 2012-08-08 | — | — | EP | disclosed |
| WO-2011040874-A1 | TESTING SYSTEM FOR DETERMINING HYPOXIA INDUCED CELLULAR DAMAGE | CALMARK SWEDEN AKTIEBOLAG (SE) | 2011-04-07 | — | — | WO | disclosed |
| EP-1515143-B1 | METHOD OF ASSAY BY OXIDATION-REDUCTION REACTION WITH FORMAZAN | ARKRAY INC (JP) | 2009-01-07 | — | — | EP | disclosed |
| US-7381539-B2 | Method of assay by oxidation-reduction reaction with formazan | ARKRAY, INC. (JP) | 2008-06-03 | — | — | US | disclosed |
| US-20050202399-A1 | Method of assay by oxidation-reduction reaction with formazan | ARKRAY, INC. (JP) | 2005-09-15 | — | — | US | disclosed |
| EP-1515143-A1 | METHOD OF ASSAY BY OXIDATION-REDUCTION REACTION WITH FORMAZAN | ARKRAY, Inc. (JP) | 2005-03-16 | — | — | EP | disclosed |
| US-4056485-A | STABLE COLORED REFERENCE STANDARD FOR ENZYMATIC DETERMINATIONS | WARNER-LAMBERT COMPANY (US) | 1977-11-01 | — | — | US | disclosed |
| US-4056485-A | STABLE COLORED REFERENCE STANDARD FOR ENZYMATIC DETERMINATIONS | WARNER-LAMBERT COMPANY (US) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230390328-A1 | Bicarbonate as a Potentiator for Antimicrobial Agents | PIEZO1, CGAS, ASIC1 | RAB9A 2195/4885NPC1 3679/4885L3MBTL1 3836/4885 |
| US-20240033285-A1 | BICARBONATE AS A POTENTIATOR FOR ANTIMICROBIAL AGENTS | PIEZO1, CGAS, ASIC1 | RAB9A 2195/4885NPC1 3679/4885L3MBTL1 3836/4885 |
| US-20240374546-A1 | USES AND METHODS FOR PROMOTING INCREASED MITOCHONDRIAL MASS AND FUNCTION | TFAM, NDUFAB1, TUFM | RAB9A 2502/4885NPC1 1289/4885L3MBTL1 4507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.